Children living with sickle cell can be treated safely using hydroxyurea, 10-year trial finds

Дата публикации: 07-10-2026 22:30:11

New research shows the efficacy and safety of hydroxyurea treatment for sickle cell anemia at four low-income sites in Africa, with no increase in clinically diagnosed infections.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Optimisation des médicaments pédiatriques contre la drépanocytose : priorités en matière de recherche et développement chez l’enfant	0	6.98	03-09-2026
2	Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease	0	3.79	03-09-2026
3	Genschere erlöst Mohammad (19) von Jahren in der Klinik	0	14.49	06-10-2026
4	Longitudinal Metabolic Control in Children With Early-Treated Phenylketonuria	0	12.78	01-10-2026
5	New Treatment Shows Remarkable Motor Improvements in Boys With Muscular Dystrophy—in Just 12 Weeks	0	8.71	10-08-2026
6	Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis B	0	14.39	27-03-2026
7	New drug could help people stricken with valley fever	0	4.79	23-07-2026
8	GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH	0	6.94	27-04-2026
9	Teaching the immune system to control HIV	0	7.4	17-09-2026
10	Malaga's Materno Infantil hospital administers CAR-T therapy to child with leukaemia for the first time	0	10.4	04-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.85. Источник: medicalxpress.com.